Search page

“All-You-Can-Eat”: Omalizumab as a Curative Treatment for Severe Food Allergies – A Case Report

A Novel Treatment for Drug-Induced Acute Interstitial Nephritis: Benralizumab

A Phase 3 Open-Label Trial-In-Progress Evaluating Garadacimab For Prophylactic Treatment Of Pediatric Patients (Aged 2–11 Years) With Hereditary Angioedema

A Semi-Quantitative Evaluation of Leniolisib Treatment Response Through a Physician Survey of Patients with Activated PI3Kδ Syndrome (APDS) Under an Early Access Programme (EAP)

A Study Conducted in the Environmental Exposure Chamber (EEC) to Assess Onset of Action of Combination of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Dymista) in the Treatment of Allergic Rhinitis Symptoms Compared to Placebo

A possible integrated mind-body approach to CSU treatment

A retrospective analysis of patients with chronic spontaneous urticaria in treatment with Omalizumab conducted in Brescia

Abatacept (cytotoxic T lymphocyte antigen 4-fragment crystallizable) treatment suppressed disease activity in a mouse model of Eosinophilic CRS

Adherence to Long-Term Prophylaxis for Hereditary Angioedema and the Impact on On-demand Treatment Claims in the US

Adjuvant allergen fusion proteins for the treatment of allergies

Adrenaline treatment in food-induced anaphylaxis – data from the European Anaphylaxis Registry

Adrenaline-use during the acute treatment of anaphylaxis – data from the European Anaphylaxis Registry

Advances in Chronic Urticaria treatment

Advances in LTP allergy: mechanisms, diagnosis, and treatment

AhR ligands in the treatment of atopic dermatitis

Algorithm for preventative treatment of viral infections reverses the negative impact of atopic traits on day-care absenteeism of preschool children

Allergenicity and Immunogenicity of Polypeptide-Conjugated Hepatitis B Core Antigen Virus‐Like-Particle (HBcAg-VLP) Vaccine for Treatment of Shellfish Allergy

Anaphylaxis during OIT and its impact on treatment adherence: a monocentric retrospective study

Anti IgE for the treatment of chronic urticarial

Anti-interleukin-5 treatment in patients with severe eosinophilic asthma provides consistent symptom control for at least 8 years

Anxiety Associated with On-Demand Treatment for Hereditary Angioedema Attacks

Anxiety Associated with Parenteral On-Demand Treatment for Hereditary Angioedema Attacks in Patients from Italy

Application Study on the prevention and treatment of spleen aminopeptide oral solution on seasonal allergic rhinitis

Assessing specific pro-catabolic mediators (SPMs) as Innovative Biomarkers in Allergen Immunotherapy: Monitoring Treatment Efficacy

Assessing the Impact of Dupilumab Treatment on Lung Function in Patients With Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

Assessment of the safety of allogenic natural killer cells in the treatment of metastatic colon cancer

Association between obesity and repeated epinephrine administration for treatment of anaphylaxis: a Taiwan tertiary hospital experience from 2001 to 2020

Association of Antenatal Corticosteroid Treatment with Risk of Allergic Diseases in Children

Asthma control, lung function, and quality of life in pediatric patients with severe asthma undergoing biological treatment

Atipic aggressive systemic mastocytosis in treatment with Avapritinib: a case report

Autoantibodies to interferon-gamma: clinical features, treatment outcomes, and in-vitro monitoring of disease

Autoimmunity in allergic diseases: implications for treatment

Balancing HAE and pregnancy: treatment recommendations and approaches

Baseline Characteristics of Patients with Severe Asthma in Spain according to biological treatment use: BREATHE study

Baseline Predictors of Multicomponent Clinical Remission Following Dupilumab Treatment in Patients With Moderate-to-Severe Asthma

Basophil FceRI expression-A management tool in anti-IgE treatment of allergic asthma

Belimumab treatment rapidly restores B cell homeostasis and reduces atypical T-bet+ B cell expansion in patients with systemic lupus erythematosus disease

Benralizumab as treatment in a patient with Near-Fatal Asthma exacerbation

Berotralstat Use Reduced Number of HAE Attacks Requiring Treatment or Professional Care in Pediatric Patients: Interim Results from APeX-P

Beyond elimination: Total diet approach for prevention and treatment of allergic disease

Beyond the future – perspectives in the diagnosis and treatment of allergy and asthma

Biological treatment in asthmatic diseases

Biomarker-guided approach for treatment of preschool asthma

Biomarkers for Atopic Dermatitis: Towards Personalized Treatment

Brazilian Anaphylaxis Registry: Main triggers, clinical manifestations and treatment

Challenges in the treatment of CRSwNP with biologics

Changes in the attacks’s frequency during Lanadelumab treatment in patients with hereditary angioedema from Romania

Characteristics of patients with severe asthma undergoing biological treatment at a reference center

Characterization of Patients With Asthma Initiating Dupilumab Treatment in a Real-World Setting: The RAPID Registry

Characterization of patients with Eosinophilic Esophagitis and response to first-line treatment in a Portuguese Immunoallergology Department

Chronic spontaneous urticaria with wheals, angioedema, or both: Differences in clinical characteristics, biomarkers and treatment response

Chronic urticaria across the ages: clinical features, comorbidities, and treatment response

Clinical Characteristics and Treatment Response of Eosinophilic Esophagitis in Pediatric Patients: A Descriptive Study from a High-Complexity Colombian Institution

Clinical Characteristics, Diagnosis, And Treatment Outcomes In Chronic Cold Urticaria: Insights From A 15-Year Study

Clinical and Treatment Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps by Treating Physician Specialty: Results from an EU Chart Review Study

Clinical characteristics and unmet treatment need in patients with hereditary angioedema treated with long-term prophylaxis: A real-world survey

Clinical effects of dupilumab in patients with rhinosinusitis, nasal polyposis, and severe uncontrolled asthma with t2 phenotype, after 12 months of treatment

Clinical evaluation of an immunotherapy treatment with Vespa velutina venom in allergic patients. Results from a prospective multicenter Study: W-STING Study

Clinical experience with newer systemic treatment for moderate to severe atopic dermatitis in children and adolescents: a single-centre study

Closing Gaps in HAE Management: Addressing Delays in On-Demand Treatment

Comparative Gene Expression Analysis in Blood Samples and Nasal Polyps during Dupilumab Treatment for CRSwNP

Comparison of the efficacy of subcutaneous and sublingual immunotherapy for the treatment of allergic asthma in children

CosMx™ single cell spatial imaging identifies changes in spatial cell communication in chronic rhinosinusitis with nasal polyps following anti – IL-5 treatment

Cutaneous Manifestations in Inborn Errors of Immunity: A Retrospective Analysis of Prevalence, Phenotypes, and Treatment Outcomes

Decoding Asthma Therapies: Transcriptomic differences between benralizumab and mepolizumab treatment in patients with severe eosinophilic asthma

Decreased frequency and severity of oral immunotherapy induced gastrointestinal eosinophilic reactions following revisions in treatment protocol

Delayed On-demand Treatment of Hereditary Angioedema Attacks: Patient Perceptions and Associated Barriers

Demographic Features Of Allergic Rhinitis Patients and Effect of Nasal Corticosteroid Treatment

Descriptive Study of Chronic Urticaria Under Treatment with Omalizumab: Our Experience

Descriptive and Comparative Analysis of Clinical and Endoscopic Characteristics and Treatment Response in Adult Patients with Eosinophilic Esophagitis (EoE): a preliminary experience of an Italian centre

Diagnosis and Treatment of Allergies at ENT Department of General Hospital of Nafplio, Greece

Diagnosis and treatment of allergies to emerging and locally relevant insects

Donidalorsen for the treatment of hereditary angioedema: Results from a phase 3, randomised, placebo-controlled trial

Dose reduction of dupilumab at 24 months of treatment in patients with controlled atopic dermatitis

Dupilumab Treatment Reduces IgE Levels in Patients Aged 2 to 17 Years With Atopic Dermatitis, Asthma, and Eosinophilic Esophagitis

Dupilumab Treatment is Associated with Clinical Improvement and a Shift towards a health-associated Nasal Passage Microbiota in Diffuse Type 2 Chronic Rhinosinusitis

Dupilumab as effective treatment for chronic pruritus: a case report

Dupilumab for Treatment of Eosinophilic Gastrointestinal Disease in children

Dupilumab for the treatment of refractory severe chronic spontaneous urticaria

Dupilumab treatment effectively reduces nasal type 2 cytokine production following acetylsalicylic acid provocation in N-ERD patients

Dupilumab treatment leads to clinically meaningful improvements in a range of symptoms and quality of life in patients with eosinophilic esophagitis: Post hoc analysis of LIBERTY EoE TREET

EAACI & AAAAI Joint Symposium : The Microbiome: A target for treatment and/or prevention of allergic disease

EAACI & AAAAI Joint Symposium – Atopic Dermatitis 2025: Novel Pathophysiology & Treatment Insights

EAACI & JSA Joint Symposium : New Insights into the Mechanism and Treatment Strategies for Unified Airway Disease

Early Responders within One Month of Dupilumab Treatment for Chronic Rhinosinusitis with Nasal Polyps

Effect of anti IL-5/IL-5Rα biological treatment on tissue eosinophil subpopulations in patients affected by Chronic Rhinosinusitis with Nasal Polyp

Efficacy and Safety of 1-Year Dupilumab Treatment in Children Aged 6-11 years with Moderate-to-Severe Atopic Dermatitis in South Korea: Multicenter Prospective Observational Study

Efficacy and Safety of the Oral Bradykinin B2 Receptor Antagonist Deucrictibant Immediate-Release Capsule in Treatment of Hereditary Angioedema Attacks: RAPIDe-3 Phase 3 Trial Design

Efficacy and safety of Mepolizumab in treatment of eosinophilic granulomatosis with polyangiitis

Efficacy of Dupliuzumab in the treatment of atopic dermatitis complicated by chronic rhinosinusitis with nasal polyps

Efficacy of Re-treatment with Omalizumab in Adults with Chronic Spontaneous Urticaria who Relapsed after Treatment Withdrawal

Efficacy of two years of treatment with anti-IL-5/R therapy for reduction in use of oral glucocorticoids in patients with eosinophilic granulomatosis with polyangiitis

Elevating patient treatment outcomes in Severe Asthma

Elevating patient treatment outcomes in Severe Asthma & comorbid CRSwNP

Emergency treatment of anaphylaxis

Emerging Biologic Use May Reduce the Need for Corticosteroid Treatment and Surgery for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in France, Germany, Italy, Spain and the UK

Empowering Patients: Innovations in Allergic Rhinoconjuntivitis treatment

Endotyping chronic rhinosinusitis for a better treatment approach

Environmental impact of asthma treatment

EoE treatment

Eosinophilia over dupilumab treatment in asthma patients: a multicentric retrospective study

Eosinophilic esophagitis in children and adolescents: clinical, endoscopic, histologic findings, and response to treatment with: fluticasone, budesonide, proton inhibitors and dupilumab

Evaluating the Impact of Leniolisib Treatment on Symptoms and Health-Related Quality of Life (HRQoL) in Activated PI3Kδ Syndrome (APDS)

Evaluation of patients’ expectation and benefits of sublingual Named-Patient Products in the treatment of allergic respiratory diseases: the French ERAPP prospective cohort study

Evolution of health-related quality of life and disease control during the first year of Lanadelumab treatment in Romanian patients with Hereditary Angioedema due to C1-inhibitor deficiency

Exploring potential predictive factors for time to response to Omalizumab treatment in a Romanian subset of patients with Chronic Spontaneous Urticaria

Food oral immunotherapy monitoring with OITcontrol® is related to reduced number of home adverse reactions and better treatment compliance compared with paper-based monitoring

GSK – Elevating patient treatment outcomes in severe asthma and CRSwNP

Health Care Situation in the Treatment of Uncontrolled GINA 4/5 Asthma Patients in Germany: 2019 vs. 2022

Health-Related Quality of Life and Clinical Characteristics in People Living with Hereditary Angioedema Prescribed Long Term Prophylaxis Alone and On-Demand Treatment Alone

Healthcare Provider Burden associated with the treatment of attacks in patients with hereditary angioedema in Latin America: A Pilot Study

Hereditary Angioedema Attack Diary Determination of the Effect of Mobile Application on Patients’ Quality of Life and Treatment Compliance Level

Hereditary Angioedema in Bulgaria: an update on patient characteristics and treatment modalities

Home-based introduction of egg protein in paediatric IgE-mediated Egg allergy – a review of treatment strategy 2011-2021 at Midland Regional Hospital Portlaoise

How to deal with insufficient response to biologic treatment in CRSwNP

How to manage treatment of a red eye

ILIT.NU: Titration of Allergen for Treatment of Grass Pollen Induced Rhinoconjunctivitis with Intralymphatic Immunotherapy

Identifying Key Outcomes in the Treatment of Activated PI3K Delta Syndrome: Results From a Modified Delphi Panel

Immune skewing and the impact on treatment response in adult asthma

Impact of Delayed Treatment of Hereditary Angioedema Attacks: Insights from Patient Surveys Across France, the United Kingdom, and the United States

Impact of liquid sublingual immunotherapy on asthma worsening prevention: GINA treatment stepping up results from the real-world EfficAPSI study

Impact of molecular allergy tests on diagnosis and treatment of eosinophilic esophagitis

Inborn errors and treatment modalities

Individualized treatment strategy in our unit in patients with predominantly Api m 10 sensitization profile

Inhaled Corticosteroid Reduction Effects on Asthma Outcomes after Three Years of Benralizumab Treatment in Severe Asthma Patients

Initial Results from SPOTLIGHT, a Phase 1b/2a Dose Escalation Study of the anti-c-Kit Briquilimab Antibody in Adults with Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite H1-Antihistamine Treatment

Insights from Benralizumab Treatment

International Eczema Council symposium : Safety of JAK inhibitors in the treatment of inflammatory skin diseases

Is milk oral immunotherapy using a home up-dosing protocol a viable and safe treatment for the older milk allergic child?

JAK Inhibitors for Atopic Dermatitis: A New Frontier in Treatment

JAK inhibitor treatment for inborn errors of Inborn Errors of Immunity (IEI).

Janus kinase inhibitors treatment for solid organ transplant associated graft versus host disease

Lichen Planus induced by treatment of severe eosinophilic asthma with biological therapy

Lichen planus following dupilumab treatment in patients with severe asthma and nasal sinus polyposis

Long-Term Dupilumab Treatment is Not Associated With an Increased Overall Risk of Infections in Patients Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis in an Open-Label Extension Study

Long-Term Prophylactic Treatment With Oral Deucrictibant Improves Disease Control and Health-Related Quality of Life in Participants With Hereditary Angioedema in the CHAPTER-1 Open-Label Extension Study

Long-Term Safety and Efficacy of Oral Deucrictibant for Treatment of Hereditary Angioedema Attacks: Results of the RAPIDe-2 Extension Study

Long-term safety of donidalorsen for the treatment of hereditary angioedema: Results from the phase 3 open-label extension OASISplus study

Lymphocyte profile and asthma control during the treatment with benralizumab in real life

MY006: A Trispecific Antibody Blocking Four Allergenic Epitopes For the Treatment of Peanut Allergy

MY006: anti-allergen multispecific antibody for the treatment of peanut allergy

MY010: An Anti-Allergen Multispecific for the Treatment of Multiple Tree Pollen Allergies

MY010: anti-allergen antibodies for the treatment of Fagales pollen allergy

Meta-analysis of primary endpoint of PQ Grass field studies with optimized dose and treatment regimen of PQ Grass

Missense variant KIT p.D816V suggestive of mast cell disorder predisposes to Hymenoptera venom immunotherapy treatment complications and failure

Modification of biologic treatment in Super-responders

Monitoring for early warning signs of asthma attacks and response to treatment with oral corticosteroids using the Albus Home contactless monitoring system

NERD treatment options: from past to future

Nasal obstruction in children: diagnosis and treatment

Natural history and treatment of food allergy

Nebulized inhaled epinephrine versus epinephrine autoinjector for the treatment of food-induced anaphylaxis in young children – a randomized controlled clinical trial

New strategies in the treatment of severe asthma

New treatment options in childhood atopic dermatitis

Next-Generation cellular therapy: should CAR-T cells be considered for allergy and asthma treatment

Novel Treatment Approaches for Patients with SM and Mediator-Related Symptoms

Novel treatment approaches in AR: AIT, Biolgicis or the combination?

Omalizumab as preventive treatment in patients with primary mast cell activation syndromes

Opening and Introductions: Challenges with Delays in On-demand Treatment

Oral Sebetralstat for On-demand Treatment of Hereditary Angioedema: Phase 3 KONFIDENT Trial Results

Oral immunotherapy (OIT) in walnut and hazelnut co-allergic patients: ELISA inhibition studies to direct treatment approach

Patient-Reported Benefits of Early On-demand Treatment of HAE Attacks

Pectin dietary supplementation as potential treatment of lipid transfer protein allergy

Polistes gallicus: an alternative treatment for European paper wasp venom allergic patients?

Precision treatment for allergic diseases

Predicting treatment response to oral immunotherapy in peanut-allergic children using multi-omics risk scores

Predictive role of peripheral blood Plasma MRGPRX2 expression to the response of anti-histamine treatment in the Chronic spontaneous urticaria patients

Predictors of Relapse After Omalizumab Withdrawal in Adults with CSU with complete response to treatment

Predictors of Treatment Response to Biological Therapy in Patients with Severe Asthma: Insights from Induced Sputum Analysis

Preimplantation genetic testing in hereditary angioedema: prevention outperforms treatment

Prevalence and impact of allergic comorbidities in patients with severe atopic dermatitis in treatment with Dupilumab

Profile of patients treated with the 300IR liquid sublingual immunotherapy for cat allergy and perception of treatment effect: Results from a French survey

Prophylactic Treatment with Oral Deucrictibant Improves Health-Related Quality of Life of Patients with Hereditary Angioedema

Proteomic Modulation by Dupilumab in Severe Seasonal Asthma: Insights from a Short-Term Treatment Study in Ole e 7-Sensitized Patients

Psoriasis, allergic rhinitis, biological treatment and immunological therapy – a case report

The efficacy in treatment of facial melasma combined with thulium 1927-nm fractional laser and topical H2R antagonist: a split-face, single-blind study

Rationale and Design of the ALPHA-SOLAR Clinical Trial of STAR-0215 for the Treatment of Hereditary Angioedema (HAE)

Real-life experience and the safety of Immunobiologicals in the treatment of immunoallergic diseases

Real-world efficacy of dupilumab as a second-line treatment in severe asthma- data from a tertiary pulmonary centre

Redefining STAT5B N642H Gain of function Mutation: Unique Phenotypic Features and First Successful Mepolizumab Treatment in a Pediatric Case

Registry on Severe Asthma with and without biological treatment in Spain: Results of a 2 year follow-up of AlergoDATA

Regulatory Perspectives on Food Allergy Treatment and Research

Relapse Rate and Risk Factors After Omalizumab Treatment in Adolescents with Chronic Spontaneous Urticaria

Remibrutinib demonstrates sustained control of angioedema in patients with chronic spontaneous urticaria: 52-week treatment results from the phase 3 REMIX studies

Response to benralizumab in severe vernal keratoconjunctivitis after treatment failure with omalizumab

Risk Factors for Early Adverse Events of Sublingual Immunotherapy for Allergic Rhinitis and their Impact on Short-term Treatment Outcomes

Risk stratification in primary care: how to use data to identify people in primary care at risk of harm due to under or over treatment and to prioritise their care

Risk stratification of drug allergy in children with immediate or delayed urticaria during antibiotic treatment

Role of The Gut Microbiome in Food Allergy: Potential For Prevention and Treatment

Role of biologics in the treatment for inborn errors of Inborn Errors of Immunity (IEI).

SEP-631: A Novel Selective and Potent Oral MRGPRX2 Inhibitor for the Treatment of Chronic Spontaneous Urticaria

SPOTLIGHT: A Phase 1b/2a, Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients with Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment with H1-Antihis

Safety and Efficacy of Oral Deucrictibant for Treatment of Upper Airway and Laryngeal Hereditary Angioedema Attacks: Results from the RAPIDe-2 Extension Study

Safety and tolerance response of a two day rush protocol treatment in immunotherapy using purified Apis mellifera dry Honeybee venom extract

Safety of a cluster strategy, effectiveness and immunological changes in allergic children sensitized to house dust mites with native and modified subcutaneous immunotherapy treatment

Sanofi : What’s New in CRSwNP? Real-Life Experiences and Current Treatment Goals

Sebetralstat as Oral On-demand Treatment for Hereditary Angioedema: Interim Analysis of Demographics and Attack Characteristics from the Open-label KONFIDENT-S Trial

Sebetralstat for Treatment of HAE Attacks in Patients Receiving Berotralstat, Lanadelumab, or C1 Inhibitor for Long-term Prophylaxis: Interim Analysis from KONFIDENT-S

Selecting the right immunotherapy for Vespa velutina nigrithorax anaphylaxis: does one treatment fits all?

Sequence of improvements in objective and patient-reported outcomes with dupilumab treatment in patients with chronic rhinosinusitis with nasal polyps: Analysis of the SINUS-52 study

Should dupilumab be the standard first treatment choice for severe atopic dermatitis?

Skin as the target for allergy prevention and treatment

Stratification Value of Nasal Brushing Arachidonate 15-Lipoxygenase in Stapokibart (CM310) Treatment for Patients with Seasonal Allergic Rhinitis: Results from MERAK

Study of olfaction in patients with chronic rhinosinusitis with nasal polyposis undergoing Mepolizumab treatment

Study on the target level and influencing factors of dupilumab treatment in children with moderate to severe atopic dermatitis

Sub-study from the EAACI allergy educational needs in Primary Care Paediatricians to gauge association of GDP impact on differences of allergy diagnosis and treatment healthcare

Subcutaneous administration of a novel Virus-like Particle Vaccine for the Treatment of Peanut Allergy is safe and well tolerated

Subcutaneous immunotherapy with mannan-conjugated birch pollen allergoids is safe in a pre/co-seasonal treatment regimen – a subgroup comparison

Successful Treatment of Post-Orgasmic Illness Syndrome with Omalizumab: A Report on Two Case

Successful treatment of lichen amyloidosis with dupilumab treatment: a case report

Successful treatment of severe asthma after switch of biologics. A case report

Successful treatment of upadacitinib in prurigo nodularis: a case report and review of the literature

Sustained reduction in Severe Asthma Exacerbations and Hospitalisations in the 12 months after Alpine Altitude Climate Treatment

Sympout study: Need of medication for symptom control in patients with rhinitis and/or bronchial asthma due to house dust mites or pollens in treatment with sublingual immunotherapy in a standardized liquid formulation in TBU/ml

Systematic literature review and adjusted indirect treatment comparisons of 2 allergen immunotherapy treatments for grass pollen–induced allergic rhinitis

Systemic Treatment of Atopic Dermatitis in Pregnancy: The Physician’s Perspective

Targeted drug-induced apoptosis in key cellular mediators of allergic asthma as a new treatment strategy

Targeting MRGPRX2 for the Treatment of Mast Cell-Driven Diseases

The Effect of Japanese cedar pollen SLIT-tablets increases with years of treatment

The Use of Long-acting Muscarinic Antagonist (LAMA) in the Treatment of Asthma: A Tertiary Asthma Center Experience

The autologous serum skin test (ASST) predicts the response to anti-IgE treatment in Chronic Spontaneous Urticaria patients: a prospective study

The effect of tezepelumab treatment on the incidence of asthma exacerbations co-occurring with acute respiratory illnesses attributed to infections: results from a pooled analysis of the PATHWAY and NAVIGATOR studies

The effectiveness and safety of Abrocitinib treatment for severe atopic dermatitis in the real-world data in Turkey

The evolution of HAE: Classification and goals of treatment

The formula of periocular eczema treatment gel prevents skin penetration of allergen extracts Phleum pratense and Dermatophagoides pteronyssinus

The impact of limited access to On-Demand Treatment for Hereditary Angioedema on Quality of life: a comparison between two income settings

The impact of treatment switching on healthcare resource utilization among patients with hereditary angioedema in the United States

The individual benefit of subcutaneous immunotherapy with mannan-conjugated birch pollen allergoids is already evident in the first season immediately after treatment

The role of immunonutrition in the treatment of food allergies in children

The successful resolve of nasal polyps in patient with dupilumab treatment

The treatment of eosinophilic asthma with mepolizumab and benralizumab: relative effectiveness

Therapeutic effectiveness and safety of cannabinoids in the treatment of atopic dermatitis: a systematic review

Tips and tricks for biological treatment of CRSwNP: setting the indication, choosing the right biological, managing side effects, switching, tapering

Toward Optimal disease control: impact of maintenance inhaler therapy and device transition in severe asthma patients undergoing monoclonal antibody treatment

Treatment Dilemmas in CARMIL2 Deficiency

Treatment Patterns in Patients Who Initiated Dupilumab in a Real-World Clinical Setting: The RAPID Registry

Treatment insights and potential differences

Treatment of Chronic Spontaneous Urticaria with Omalizumab Complicated by Onychodystrophy?

Treatment of Chronic Spontaneous Urticaria with Omalizumab during Pregnancy- Experience in a Portuguese Ucare

Treatment of HAE Attacks with Anticipated Future Oral On-demand Therapies as Reported by Patients

Treatment of atopic dermatitis patients with dupilumab restores functional responses of circulating skin-homing CD4+ T and B cells

Treatment of different asthma endotypes

Treatment of insulin allergy by intranasal Fc-fused preproinsulin

Treatment of refractory urticaria in children

Treatment of severe asthma (update)

Treatment of severe atopic dermatitis in pediatric patients with Dupilumab and effects of therapy on nasal and skin microbiota: preliminary experimental evidence

Treatment response in severe asthma: from rehabilitation to biologic

Treatment satisfaction and health literacy among patients undergoing allergen-specific immunotherapy -Data from a tertiary allergy centre

Understanding treatment switching patterns and continuation rates for patients with hereditary angioedema receiving lanadelumab: analysis of real-world data

Urticaria in the context of treatment with trimethoprim/sulfamethoxazole due to trimethoprim sensitization

Use of Dupilumab as Adjuvant Treatment in Oral Food Desensitization: A Case Report

Use of inactivated polybacterial mucosal vaccine (IPMV) as part of the treatment for the reduction of recurrent acute respiratory infections

Use of ketotifen as treatment for post viral infection cough in children

Validation of an Adapted Treatment Burden Questionnaire for Paediatric IgE-Mediated Milk and Egg Allergies: A Multicentre Study

Weighing the Pros and Cons of systemic steroids in CRS treatment

What is the optimal time for diagnosis and treatment of peanut allergy in children?

What’s new in CRSwNP? Real-Life experiences and current treatment goals

Which treatment to choose in AD patients with ocular disease?

Аnti-inflammatory effect of extracorporeal shock wave therapy as treatment for chronic calculous prostatitis

Investigation Of Treatment Responses And Clinical Characteristics Of Patients With The Late-Onset Asthma Phenotype Under Biological Treatment

KalVista Pharmaceuticals – Closing Gaps in HAE Management: Addressing Treatment Delays in On-Demand Treatment

Patients with severe eosinophilic asthma starting anti-IL5 treatment after 2018 have better preserved lung function compared to the patients who started treatment earlier

Self-reported treatment preferences of patients switching from prior prophylactic therapies to donidalorsen for the treatment of hereditary angioedema: Results from the phase 3 OASISplus study

Treatment with Barzolvolimab Leads to Sustained Improvement in Angioedema in Chronic Spontaneous Urticaria (CSU) patients: Results from 52 Weeks of Treatment

Use of the AllergyVax Doctor app to evaluate the correlation between adherence to treatment and control of rhinitis and asthma in patients during treatment with SLIT

Welcome

Only match titles

What are you looking for?

Knowledge Hub

Website